Abstract
Limited progress in the treatment of multiple myeloma (MM) has been obtained since the introduction of melphalan more than 20 years ago.Response rates to conventional therapy are only in the order of 50% and median survival averages two to three years. Prognosis is related to tumor load at presentation and, especially for patients with high tumor mass, new therapeutic modalities appear necessary.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Selby PJ, McElwain TJ, Nandi AC, et al. Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 1987;66:55–62.
Garthon G, Tura S, Flesch M, et al. Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to EBMT registry. Hematol Oncol 1988;6:181–6.
Wolff SN, McCurley TL, Giannone L. High dose chemoradiotherapy with syngeneic marrow transplantation for multiple myeloma: A case report and literature review. Amer J Haemat 1987;26:191–8.
Barlogie B, Alexanian R, Dicke KA, et al. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987;70:869–72.
Bell AJ, Hamblin TJ, Oscier DG. Circulating stem cell autografts. Bone Marrow Transplant 1986;1:103–10.
Clofent G, Klein B, Commes T, et al. No detectable malignant B cells in the peripheral blood of patients with multiple myeloma. Br J Haemat 1989; 71:357–61.
Gore ME, Selby PJ, Viner C, et al. Intensive treatment of multiple myelo- ma and criteria for complete remission. Lancet 1989;i:879–82.
Fermand JP, Levy Y, Gerota J, et al. Treatment of aggressive multiple myeloma by high dose chemotherapy and total body irradiation followed by blood stem cell autologous graft. Blood 1989;73:20–3.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fermand, J.P. et al. (1991). High Dose Chemotherapy and Blood Stem Cell Autologous Graft in Multiple Myeloma. In: Sibinga, C.T.S., Kater, L. (eds) Advances in haemapheresis. Developments in Hematology and Immunology, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3904-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3904-9_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6742-0
Online ISBN: 978-1-4615-3904-9
eBook Packages: Springer Book Archive